3
Announcements
Trials
Browse
Landscape
Status
Recruiting
7
Completed
5
Unknown
2
Not yet recruiting
2
Withdrawn
1
Terminated
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasms
13
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
5
Prostatic Neoplasms
4
Neoplasm Metastasis
3
Melanoma
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Multiple Myeloma
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioblastoma
2
Fibrosis
2
Colorectal Neoplasms
2
Cachexia
2
Vascular Malformations
1
Uterine Cervical Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Renal Insufficiency, Chronic
1
Recurrence
1
Pneumonia
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Osteosarcoma
1
Obesity
1
Interventions
Temozolomide
22
Bevacizumab
10
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Irinotecan
5
Carmustine
4
fluorodopa F 18
3
Topotecan
3
Surgical Procedures, Operative
3
Standard of Care
3
Radiosurgery
3
Magnetic Resonance Imaging
3
Congresses as Topic
3
Carboplatin
3
Aminolevulinic Acid
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
ribociclib
2
poly ICLC
2
fluoromisonidazole
2
carmustine, poliferprosan 20 drug combination
2
cabozantinib
2
Vorinostat
2
TIC10 compound
2
Re-Irradiation
2
Radiotherapy, Intensity-Modulated
2
Panobinostat
2
O(6)-benzylguanine
2
Melphalan
2
Lomustine
2
Lacosamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Glioma
×
Blood Specimen Collection
×
Clear all
NCT00473408
2016-12-06
Gliomstudien
Haukeland University Hospital
Terminated
1 enrolled